Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Suven Life Sciences synthesizes new cognition-enhancing drug candidates

April 20, 2012

Eisai presents PARP inhibitor with promising anticancer activity

April 19, 2012

Potent ROCK inhibitors with oncolytic potential identified in U.S.

April 19, 2012

Novel antimalarials identified through phenotypic whole-cell screening

April 19, 2012

Novel microRNA-based drug shows potential to treat liver cancer

April 19, 2012

Potential new antidepressant has promising pharmacokinetic profile

April 19, 2012

Investigators in U.S. link desaturase to survival of patients with breast cancer

April 19, 2012

Highly potent and selective EZH2 inhibitors discovered by GSK

April 18, 2012

Preclinical results demonstrate significant early antitumor efficacy of new immunotherapy

April 18, 2012

Sanofi presents novel oncolytic drug candidate

April 18, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...